JERSEY CITY, N.J., Nov. 1, 2012 /PRNewswire/ — Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) today announced the Company's financial results for the quarter ended September 30, 2012.(Logo: http://photos.prnewswire.com/prnh/20090413/LA97352LOGO …
NewYork-Presbyterian Hospital Receives Two Awards for Organ Transplant Performance
NewYork-Presbyterian Hospital/Columbia University Medical Center was named a recipient of two Transplant Program Awards from the U.S. Department of Health and Human Services (HSS) for its outstanding performance on liver and lung transplantation.
Smartphones Poised to Revolutionize Heart Failure Monitoring – Family Practice News Digital Network
Smartphones Poised to Revolutionize Heart Failure MonitoringFamily Practice News Digital NetworkSEATTLE – Smartphones may soon be harnessed for monitoring patients with heart failure, offering advantages such as remote assessment and early prediction…
Boston Scientific Boosts Portfolio – Analyst Blog – NASDAQ
Boston Scientific Boosts Portfolio – Analyst BlogNASDAQBoston Scientific 's ( BSX ) coronary stent portfolio was boosted with the CE Mark approval of its Synergy everolimus-eluting platinum chromium stent. The product features everolimus drug coati…
UT Austin Opens Lab Crucial to Drug Development Process
AUSTIN — The University of Texas at Austin is opening a laboratory that fills a critical gap in the process of developing new drugs and biotechnology products.
Living donors fare well following liver transplantation – Medical Xpress
Living donors fare well following liver transplantationMedical XpressResearchers in Japan report that health-related quality of life (HRQOL) for donors following living donor liver transplantation (LDLT) was better than the general Japanese population …
Family of baby girl with severe heart condition face desperate wait for organ to save her life
Miley Turbitt, from South Shields, is at the top of the European transplant list after being diagnosed with a rare heart condition.
Optimer advances anti-superbug trial
Optimer Pharmaceuticals has started an advanced trial of its drug Dificid to prevent C. diff diarrhea in bone marrow transplant patients.
Living donors fare well following liver transplantation – Science Codex
Living donors fare well following liver transplantationScience CodexResearchers in Japan report that health-related quality of life (HRQOL) for donors following living donor liver transplantation (LDLT) was better than the general Japanese population (…
MSPs give personal testimonies in organ donor debate – BBC News
BBC NewsMSPs give personal testimonies in organ donor debateBBC NewsMSPs have given emotional testimonies in a debate on whether there should be presumed consent for organ donation. Labour member Mark Griffin spoke about the death of his father followi…